| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019018138 |
| P356 | DOI | 10.1186/BCR1629 |
| P932 | PMC publication ID | 1797023 |
| P698 | PubMed publication ID | 17181859 |
| P5875 | ResearchGate publication ID | 6618191 |
| P50 | author | Alfred I. Neugut | Q107503728 |
| Regina M. Santella | Q113619023 | ||
| Mary Beth Terry | Q75067963 | ||
| Susan L Teitelbaum | Q93243028 | ||
| Marilie Gammon | Q104751082 | ||
| P2093 | author name string | Jing Shen | |
| P2860 | cites work | Alternative polyadenylation of cyclooxygenase-2. | Q24798039 |
| Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma | Q25255846 | ||
| Relationship between cyclooxygenase 8473T>C polymorphism and the risk of lung cancer: a case-control study | Q25257445 | ||
| A New Statistical Method for Haplotype Reconstruction from Population Data | Q27860495 | ||
| Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk | Q28168742 | ||
| Aspirin and breast cancer prevention: the estrogen connection | Q28168745 | ||
| Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer | Q28168820 | ||
| The role of COX-2 inhibition in breast cancer treatment and prevention | Q28168853 | ||
| Risk of breast cancer among users of aspirin and other anti-inflammatory drugs | Q28169157 | ||
| Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status | Q28176257 | ||
| The proximal region of the 3'-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U | Q28186564 | ||
| Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease | Q28195395 | ||
| PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs | Q28210376 | ||
| Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort | Q28213690 | ||
| Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2 | Q28253346 | ||
| Polymorphism in the 3'-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. | Q34229483 | ||
| Targeting cyclooxygenase-2 in human neoplasia: rationale and promise | Q34287766 | ||
| Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. | Q34571903 | ||
| Fluorescence polarization in homogeneous nucleic acid analysis | Q35023029 | ||
| The role of COX-2 in breast and cervical cancer. | Q35148936 | ||
| Dysregulated post-transcriptional control of COX-2 gene expression in cancer | Q35668348 | ||
| Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer | Q36194125 | ||
| Breast cancer and NSAID use: a meta-analysis | Q36622959 | ||
| Molecular classification of breast cancer: implications for selection of adjuvant chemotherapy. | Q36642141 | ||
| Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: the Singapore Chinese Health Study | Q36695052 | ||
| Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway | Q37455567 | ||
| COX-2 gene promoter haplotypes and prostate cancer risk | Q38345290 | ||
| The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer | Q38454025 | ||
| Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts | Q38454180 | ||
| Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast | Q40534891 | ||
| Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. | Q40697859 | ||
| Prostaglandin synthase 2. | Q40941854 | ||
| Cyclooxygenase 2 polymorphism (Val511Ala), nonsteroidal anti-inflammatory drug use and breast cancer in African American women | Q43858996 | ||
| Aromatase and COX-2 expression in human breast cancers | Q43890516 | ||
| A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke | Q44103563 | ||
| Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption | Q45154644 | ||
| A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population | Q46390548 | ||
| The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk | Q46952833 | ||
| Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. | Q50636879 | ||
| Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. | Q51787247 | ||
| A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. | Q52001789 | ||
| Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. | Q53355583 | ||
| Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. | Q53629616 | ||
| Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population. | Q54597767 | ||
| Lack of Association between Polymorphisms in Inflammatory Genes and Lung Cancer Risk | Q57272147 | ||
| Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer | Q57610567 | ||
| Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer | Q74376052 | ||
| Genotype transposer: automated genotype manipulation for linkage disequilibrium analysis | Q74428447 | ||
| Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer | Q77601963 | ||
| Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium | Q81563636 | ||
| Prostaglandin-endoperoxide synthase 2 (PTGS2) gene polymorphisms and risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China | Q81638679 | ||
| Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism | Q81805957 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | R71 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk | |
| P478 | volume | 8 |
| Q43294461 | -765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies |
| Q34206458 | A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation |
| Q38191999 | Aging, nutrient signaling, hematopoietic senescence, and cancer |
| Q36081333 | Association of the -14C/G MET and the -765G/C COX-2 gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population |
| Q34119332 | Association of the three common SNPs of cyclooxygenase-2 gene (rs20417, rs689466, and rs5275) with the susceptibility of breast cancer: an updated meta-analysis involving 34,590 subjects |
| Q35527962 | Associations between ALOX, COX, and CRP polymorphisms and breast cancer among Hispanic and non-Hispanic white women: The breast cancer health disparities study |
| Q28274081 | Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward |
| Q30367680 | Cyclooxygenase-2 and the inflammogenesis of breast cancer. |
| Q34458235 | Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. |
| Q38393725 | Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies |
| Q36290438 | Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma |
| Q34351250 | Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study. |
| Q94391805 | Interaction between polyunsaturated fatty acids and genetic variants in relation to breast cancer incidence |
| Q34794017 | Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer risk |
| Q34721693 | Lack of association between COX-2 8473T>C polymorphism and breast cancer risk: a meta-analysis |
| Q36746417 | Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development |
| Q36336831 | Mechanistic aspects of COX-2 expression in colorectal neoplasia |
| Q43061636 | Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. |
| Q38444433 | Pharmacogenomics of cyclooxygenases |
| Q34294719 | Platelets and cancer: a casual or causal relationship: revisited. |
| Q41030946 | Polymorphisms in cyclooxygenase-2 gene in endometrial cancer patients |
| Q33741123 | Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study |
| Q37769274 | Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis |
| Q37475804 | Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer |
| Q37602314 | The rationale and potential of cancer chemoprevention with special emphasis on breast cancer |
Search more.